Methods for identifying genes amplified in cancer cells

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 912, 435174, 4351723, 435 691, 536 231, 536 243, 536 2433, C12Q 168, C12P 1934, C07H 2104, C07H 2102

Patent

active

057766835

ABSTRACT:
New methods are disclosed for detecting cancer associated genes, and obtaining corresponding cDNA fragments. The methods involve supplying RNA preparations from control cells, and from a plurality of different cancer cells that share a duplicated or deleted gene in the same region of a chromosome. Amplified cDNA copies are displayed, and then selected based on differences in abundance of RNA between preparations. Optional additional screening steps involve surveying panels of cancer cells using the cDNA for RNA overabundance with or without gene duplication. By applying these methods, cDNA sequences derived from four novel genes associated with breast cancer were obtained and characterized. Each of the genes was duplicated in about 60% of the cancer cell lines tested; while other cells showed RNA overabundance without gene duplication. Genes with these properties are particularly useful in cancer diagnosis and treatment.

REFERENCES:
patent: 4444887 (1984-04-01), Hoffman
patent: 4472500 (1984-09-01), Milstein et al.
patent: 4491632 (1985-01-01), Wands et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5124246 (1992-06-01), Urdea et al.
patent: 5262311 (1993-11-01), Pardee et al.
patent: 5324654 (1994-06-01), Bredsen
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5427932 (1995-06-01), Weier et al.
patent: 5447841 (1995-09-01), Gray et al.
patent: 5472842 (1995-12-01), Stokke et al.
patent: 5580726 (1996-12-01), Villeponteau et al.
Liang et al. Cancer Reserch 52: 6966-6968, 1992.
McClelland et al. DNA Fingerprinting : State of the Science, eds PEna et al., pp. 103-115, 1993.
Iwamura et al. Proceedings of the Am Assoc for Cancer Research vol. 36; A1351, 1995.
Bober et al. Proceedings of the Am Assoc. for Cancer Research vol. 36: A1352, 1995.
Orkin et al. Report and Recommendations to NIH, 1995.
Adane et al. "BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers" Oncogene (1991) 6:659-663.
Alitalo et al., "Oncogene amplification in tumor cells" Adv. Cancer Res. (1986) 47:235-281.
Altschul et al., "Optimal sequence alighment using affine gap costs" Bull. Math. Bio. (1986) 48:603-616.
Aziz et al., "The FDA's perspective on the evaluation of tumor marker tests" Clin. Chem. (1993) 39:2439-2443.
Bauer et al., "Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR)" Nucl. Acids Res. (1993) 21:4272-4280.
Beardsley "Crapshoot: manufacturers gamble on cancer vaccines-again" Scientific American (1994) Sep. 102 volume number not relevant.
Berns et al., "Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors" Cancer Res. (1992) 52:1036-1039.
Bishop, "Molecular themes in oncogenesis" Cell (1991) 64:235-248.
Bast, Jr., "Perspectives on the future of cancer markers" Clin Chem. (1993) 39:2444-2451.
Brison, "Gene amplification and tumor progression" Biochim. Biophys. Acta (1993) 1155:25-41.
Cowley et al., "A vaccine for breast cancer?" Newsweek (Nov. 1, 1993) p. 68.
Culver et al., "Gene therapy for cancer" Trends Genet. (1994) 10:174-178.
Dutrillaux et al., "Characterization of chromosomal anomalies in human breast cancer" Cancer Genet. Cytogenet. (1990) 49:203-217.
Henikoff et al., "Amino acid substitution matrices from protein blocks" Proc. Natl. Acad. Sci. USA (1992) 89:10915-10919.
Kallioniemi et al., "Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors" Science (1992) 258:818-821.
Kallioniemi et al., "Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization" Proc. Natl. Acad. Sci. USA (1994) 91:2156-2160.
Klijn et al., "The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients" Endocrine Rev. (1992) 13:3-17.
Liang et al., "Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction" Science (1992) 257:967-971.
Liang et al., "Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization" Nucl. Acids Res. (1993) 21:3269-3275.
Lippman, "The development of biological therapies for breast cancer" Science (1993) 259:631-632.
Lippman, "Growth factors, receptors, and breast cancer" J. NIH Res. (1991) 3:59-62.
MacLean et al., "The immune system, cancer antigens and immunotherapy" Contemp. Oncol. (Aug./Sep. 1992) pp. 1-7, vol. number not applicable.
Melillo, "Conjugate vaccine shows promise as stimulant of specific antibodies" Internal Medicine World Report (Jun. 1-14, 1994) p. 40, vol. number not applicable.
Mok et al., "Molecular cloning of differentially expressed genes in human epithelial ovarian cancer" Gynecologic Oncol. (1994) 52:247-252.
Morgan et al., "Human gene therapy" Ann. Rev. Biochem. (1993) 62:191-217.
Muss et al., "c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer" New Engl. J. Med. (1994) 330:1260-1266.
Roth, "Modualtion of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment" Ann. Surg. Oncol. (1994) 1:79-86.
Saint-Ruf et al., "Proto-oncogene amplification and homogeneously staining regions in human breast carcinomas" Genes Chromosomes & Cancer (1990) 2:18-26.
Slamon et al., "Human breast cancer: correlation of relapse and survival with amplification of the HER-2
eu oncogene" Science (1987) 235:178-182.
Schwab et al., "Amplification of cellular oncogenes: a predictor of clinical outcome of human cancer" Genes Chromosomes & Cancer (1990) 1:181-193.
Trentmann et al., "Alternatives to .sup.35 S as a label for the differential display of eukaryotic messenger RNA" Science (1995) 267:1186-1187.
Unsigned, "Synthetic vaccine stabilizes advanced cancer, prolongs survival" Oncol. News Int. (1994) 3:1.
Unsigned, "Biomira developing test for breast cancer recurrence" Toronto Globe and Mail (Jun. 7, 1994). 1 page total.
Watson et al., "Isolation of differentially expressed sequence tags from human breast cancer" Cancer Res. (1994) 54:4598-4602.
Wintersberger, "DNA amplification: New insights into its mechanism" Chromosoma (1994) 103:73-81.
Zafrani et al., "Cytogenetic study of breast cancer: clinicopathologic significance of homogeneously staining regions in 84 patients" Hum. Pathol. (1992) 23:542-547.
Ayala M. et al. (1995), "New primer strategy improves precision of differential display", BioTechniques 18:842-850.
Bertioli D.J. et al. (1995), "An analysis of differential display shows a strong bias towards high copy number mRNAs", Nucl. Acids Res. 23:4520-4523.
Chen Z. et al. (1995), "Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas", Molecular Med. 1:153-160.
Haag E. et al. (1994), "Effects of primer choice and source of Taq DNA polymerase on the binding patterns of differential display RT-PCR", BioTechniques 17:226-228.
Kocher O. et al. (1995), "Identification of a novel gene, selectivley up-regulated in human carcinomas, using the differential display technique", Clin. Cancer Res. 1:1209-1215.
Liang P. et al. (1992b), "Differential display and cloning of messenger RNAs in human breast cancer versus mammary epithelial cells", Cancer Res. 52:6966-6968.
Liang P. et al. (1994), "Differential display using one-base anchored oligo-dT primers", Nucl. Acids Res. 22:5763-5764.
Linskens M.H.K. et al. (1995), "Cataloging altered gene expression in young and senescent cells using enhanced differential display", Nucl. Acids Res. 23:3244-3251.
McKenzie D. et al. (1994), "Using the RNA arbitrarily primed polymerase chain reaction (RAP-PCR) to analyze gene expression in human breast cancer
Sunday M.E. et al. (1995), "Differential display RT-PCR for identifying novel gene expression in the lung", Am. J. Physiol. 269:L273-L284.
Yeatman T.J. et al. (1995), "Identification of a differentially-expressed message associated with colon cancer liver metastasis using an improved method of differential display", Nucl. Acids Res

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for identifying genes amplified in cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying genes amplified in cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying genes amplified in cancer cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1204044

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.